Acute treatment-related diarrhea during postoperative adjuvant therapy for high-risk rectal carcinoma

International Journal of Radiation Oncology Biology Physics

Volumn 41, Issue 3, 1998, Pages 593-598

  Miller, Robert C ^a   Martenson, James A ^a   Sargent, Daniel J ^a   Kahn, Michael J ^a   Krook, James E ^b  

^a MAYO CLINIC   (United States)

^b Duluth Community Clinical Oncology Program   (United States)

Author keywords

Adverse effects; Diarrhea; Pelvic radiation therapy

Indexed keywords

ANTIDIARRHEAL AGENT; FLUOROURACIL; SEMUSTINE;

ARTICLE; BOLUS INJECTION; CANCER ADJUVANT THERAPY; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; GASTROINTESTINAL TOXICITY; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; POSTOPERATIVE CARE; PRIORITY JOURNAL; RADIATION ENTEROPATHY; RANDOMIZED CONTROLLED TRIAL; RECTUM ABDOMINOPERINEAL RESECTION; RECTUM ANTERIOR RESECTION; RECTUM CARCINOMA; TREATMENT OUTCOME;

ACUTE DISEASE; ANTIMETABOLITES, ANTINEOPLASTIC; CHEMOTHERAPY, ADJUVANT; DIARRHEA; FLUOROURACIL; HUMANS; PROSPECTIVE STUDIES; RADIOTHERAPY; RADIOTHERAPY DOSAGE; RECTAL NEOPLASMS;

EID: 0031799133     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(98)00084-4     Document Type: Article

References (22)

1. Douglass H.O. Jr, Moertel C.G., Mayer R.J., Thomas P.R., Lindblad A.S., Mittelman A., Stablein D.M., Bruckner H.W. Survival after postoperative combination treatment of rectal cancer (letter to the editor). N. Engl. J. Med. 315:1986;1294-1295.
2. Prolongation of the disease-free interval in surgically treated rectal carcinoma. N. Engl. J. Med. 312:1985;1465-1472.
3. Krook J.E., Moertel C.G., Gunderson L.L., Wieand H.S., Collins R.T., Beart R.W., Kubista T.P., Poon M.A., Meyers W.C., Mailliard J.A., Twito D.I., Morton R.F., Veeder M.H., Witzig T.E., Cha S., Vidyarthi S.C. Effective surgical adjuvant therapy for high-risk rectal carcinoma. N. Engl. J. Med. 324:1991;709-715.
4. O'Connell M.J., Martenson J.A., Wieand H.S., Krook J.E., Macdonald J.S., Haller D.G., Mayer R.J., Gunderson L.L., Rich T.A. Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery. N. Engl. J. Med. 331:1994;502-507.
5. Thomas P.R., Lindblad A.S., Stablein D.M., Knowlton A.H., Bruckner H.W., Childs D.S., Mittelman A. Toxicity associated with adjuvant postoperative therapy for adenocarcinoma of the rectum. Cancer. 57:1986;1130-1134.
6. Fisher B., Wolmark N., Rockette H., Redmond C., Deutsch M., Wickerham D.L., Fisher E.R., Caplan R., Jones J., Lerner H., Gordon P., Feldman M., Cruz A., Legault-Poisson S., Wexler M., Lawrence W., Robidoux A. Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer Results from NSABP protocol R-01 . J. Natl. Cancer Inst. 80:1988;21-29.
7. Henriksson R., Franzen L., Littbrand B. Effects of sucralfate on acute and late bowel discomfort following radiotherapy of pelvic cancer. J. Clin. Oncol. 10:1992;969-975.
8. Pedersen I.K., Christiansen J., Hint K., Jensen P., Olsen J., Mortensen P.E. Anorectal function after low anterior resection for carcinoma. Ann. Surg. 204:1986;133-135.
9. Schoetz D.J. Jr. Postcolectomy syndromes. World J. Surg. 15:1991;605-608.
10. Williams N.S., Price R., Johnston D. The long term effect of sphincter preserving operations for rectal carcinoma on function of the anal sphincter in man. Br. J. Surg. 67:1980;203-208.
11. Brierley J.D., Cummings B.J., Wong C.S., McLean M., Cashell A., Manter S. The variation of small bowel volume within the pelvis before and during adjuvant radiation for rectal cancer. Radiother. Oncol. 31:1994;110-116.
12. Gallagher M.J., Brereton H.D., Rostock R.A., Zero J.M., Zekoski D.A., Poyss L.F., Richter M.P., Kligerman M.M. A prospective study of treatment techniques to minimize the volume of pelvic small bowel with reduction of acute and late effects associated with pelvic irradiation. Int. J. Radiat. Oncol. Biol. Phys. 12:1986;1565-1573.
13. Gunderson L.L., Russell A.H., Llewellyn H.J., Doppke K.P., Tepper J.E. Treatment planning for colorectal cancer Radiation and surgical techniques and value of small-bowel films . Int. J. Radiat. Oncol. Biol. Phys. 11:1985;1379-1393.
14. Mameghan H., Fisher R., Mameghan J., Watt W.H., Tynan A. Bowel complications after radiotherapy for carcinoma of the prostate The volume effect . Int. J. Radiat. Oncol. Biol. Phys. 18:1990;315-320.
15. Minsky, B. D.; Cohen, A. M. Minimizing the toxicity of pelvic radiation therapy in rectal cancer. Oncology 2:21-25, 28-29; 1988.
16. Minsky B.D., Conti J.A., Huang Y., Knopf K. Relationship of acute gastrointestinal toxicity and the volume of irradiated small bowel in patients receiving combined modality therapy for rectal cancer. J. Clin. Oncol. 13:1995;1409-1416.
17. Henriksson R., Arevarn M., Franzen L., Persson H., Stendahl U. Beneficial effects of sucralphate in radiation induced diarrhea. An open randomized study in gynecological cancer patients. Eur. J. Gynaecol. Oncol. 11:1990;299-302.
18. Quan S.H.Q. Management of bowel dysfunction following surgery. Cohen A.M., Winawer S.J., Friedman M.A., Gunderson L.L. Cancer of the colon, rectum, and anus. 1995;783-785 McGraw-Hill, New York.
19. Mennie A.T., Dalley V.M., Dinneen L.C., Collier H.O. Treatment of radiation-induced gastrointestinal distress with acetylsalicylate. Lancet. 2:1975;942-943.
20. Martenson J.A. Jr, Hyland G., Moertel C.G., Mailliard J.A., O'Fallon J.R., Collins R.T., Morton R.F., Tewfik H.H., Moore R.L., Frank A.R., Urias R.E., Deming R.L. Olsalazine is contraindicated during pelvic radiation therapy Results of a double-blind, randomized clinical trial . Int. J. Radiat. Oncol. Biol. Phys. 35:1996;299-303.
21. Chary S., Thomson D.H. A clinical trial evaluating cholestyramine to prevent diarrhea in patients maintained on low-fat diets during pelvic radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 10:1984;1885-1890.
22. Stryker J.A., Chung C.K., Layser J.D. Colestipol hydrochloride prophylaxis of diarrhea during pelvic radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 9:1983;185-190.